{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:53:05Z","timestamp":1777859585156,"version":"3.51.4"},"reference-count":36,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>The objective of this systematic review was to characterize the literature regarding the risk factors associated with the development of toxic shock syndrome (TSS) secondary to the use of intrauterine contraceptives (IUCs), as well as patient outcomes. A literature search was conducted spanning origin through December 12, 2022, using Embase and MEDLINE ALL. Primary literature that discussed development of TSS along with the presence of an IUC were included. Extracted data included study and participant demographics, IUC data, and infection data. Reports were evaluated for risk-of-bias using the Joanna Briggs Institute critical appraisal tool for case reports. Thirteen reports met the eligibility criteria, all of which were case reports involving one patient per case who developed TSS following the insertion of an IUC or in the presence of an IUC. The patients included in the review were women aged 23 to 50 years old. Major outcomes reported included time of IUD insertion, bacteria cultured, and antibiotic therapies administered. A minority of the reports (n = 5) provided data related to recent or prior childbirth, miscarriages, or abortions, some of which were proposed to have contributed to development of TSS. Risk-of-bias assessments identified potential concerns in four domains. This systematic review characterized literature pertaining to IUC use and TSS. There may be a low but possible risk of TSS when using an IUC; generalizability is limited given the low quality of available studies. This study was neither registered nor funded.<\/jats:p>","DOI":"10.1177\/08971900241313402","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:34:36Z","timestamp":1736350476000},"page":"463-472","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic Review of Intrauterine Contraceptive Use and the Development of Toxic Shock Syndrome"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1630-874X","authenticated-orcid":false,"given":"Timothy C.","family":"Hutcherson","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, D\u2019Youville University School of Pharmacy, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2861-3074","authenticated-orcid":false,"given":"Nicole E.","family":"Cieri-Hutcherson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Science, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Grosshans","sequence":"additional","affiliation":[{"name":"Cottrill\u2019s Specialty Pharmacy, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Freemire","sequence":"additional","affiliation":[{"name":"School of Pharmacy, D\u2019Youville University, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eryn","family":"Meegan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, D\u2019Youville University, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Zu","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elana","family":"Tal","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.10.121"},{"key":"e_1_3_3_3_2","unstructured":"National Organization for Rare Disorders. Toxic shock syndrome. 2009. Available at: https:\/\/rarediseases.org\/rare-diseases\/toxic-shock-syndrome\/. Accessed 4 September 2024."},{"key":"e_1_3_3_4_2","unstructured":"Centers for Disease Control and Prevention. Clinical guidance for streptococcal toxic shock syndrome. 2024. Available at: https:\/\/www.cdc.gov\/group-a-strep\/hcp\/clinical-guidance\/streptococcal-toxic-shock-syndrome.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/groupastrep\/diseases-hcp\/Streptococcal-Toxic-Shock-Syndrome.html. Accessed September 4 2024."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2012.03.020"},{"issue":"000","key":"e_1_3_3_6_2","first-page":"1","article-title":"Streptococcal toxic shock syndrome after insertion of a levonorgestrel intrauterine device","volume":"000","author":"Balayla J","year":"2019","unstructured":"Balayla J, Gil Y, Mattin J, et al. Streptococcal toxic shock syndrome after insertion of a levonorgestrel intrauterine device. JOGC. 2019;000(000):1-3.","journal-title":"JOGC"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.5.997"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00032-19"},{"issue":"11","key":"e_1_3_3_9_2","first-page":"144","article-title":"Diaphragm users should follow 13 tips for best effectiveness","volume":"5","author":"Reese M","year":"1984","unstructured":"Reese M, Hatcher RA. Diaphragm users should follow 13 tips for best effectiveness. Contracept Technol Update. 1984;5(11):144-145. https:\/\/pubmed.ncbi.nlm.nih.gov\/12313252\/","journal-title":"Contracept Technol Update"},{"key":"e_1_3_3_10_2","unstructured":"Centers for Disease Control and Prevention. Streptococcal toxic shock syndrome (STSS) (Streptococcus pyogenes) 2010 Case Definition. 2021. Available at: https:\/\/ndc.services.cdc.gov\/case-definitions\/streptococcal-toxic-shock-syndrome-2010\/. Accessed 4 September 2024."},{"key":"e_1_3_3_11_2","unstructured":"Centers for Disease Control and Prevention. Toxic shock syndrome (other than streptococcal) (TSS) case definition. 2021. Available at: https:\/\/ndc.services.cdc.gov\/case-definitions\/toxic-shock-syndrome-2011\/."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(17)30206-2"},{"key":"e_1_3_3_13_2","volume-title":"Kyleena Package Insert","year":"2016","unstructured":"Kyleena Package Insert. Whippany, NJ: Bayer HealthCare pharmaceuticals; 2016."},{"key":"e_1_3_3_14_2","volume-title":"Liletta Package Insert","year":"2019","unstructured":"Liletta Package Insert. Irvine, CA: Allergan USA, Inc.; 2019."},{"key":"e_1_3_3_15_2","volume-title":"Mirena Package Insert","year":"2022","unstructured":"Mirena Package Insert. Whippany, NJ: Bayer HealthCare Pharmaceuticals; 2022."},{"key":"e_1_3_3_16_2","volume-title":"Paragard Package Insert","year":"2019","unstructured":"Paragard Package Insert. Trumbull, CT: CooperSurgical Inc.; 2019."},{"key":"e_1_3_3_17_2","volume-title":"Skyla Package Insert","year":"2013","unstructured":"Skyla Package Insert. Wayne, NJ: Bayer HealthCare Pharmaceuticals; 2013."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_3_19_2","volume-title":"Chapter 7: Systematic Reviews of Etiology and Risk","author":"Moola S","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, et al. In: Aromataris E, Munn Z, eds. Chapter 7: Systematic Reviews of Etiology and Risk. JBI: JBI Manual for Evidence Synthesis. https:\/\/synthesismanual.jbi.global.https:\/\/doi.org\/10.46658\/JBIMES-24-06 (2020)."},{"key":"e_1_3_3_20_2","volume-title":"Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach","author":"Sch\u00fcnemann H","year":"2013","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, et al. Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach. Boston, MA: The GRADE Working Group; 2013."},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","first-page":"e00352","DOI":"10.1016\/j.crwh.2021.e00352","article-title":"Streptococcal toxic shock syndrome in the setting of recent gynecologic surgery: a case report","volume":"32","author":"Gruttadauria M","year":"2021","unstructured":"Gruttadauria M, Pollard J, Kim S, Lian X. Streptococcal toxic shock syndrome in the setting of recent gynecologic surgery: a case report. Case Rep Womens Health. 2021;32:e00352.","journal-title":"Case Rep Womens Health"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000843"},{"issue":"9","key":"e_1_3_3_23_2","first-page":"8","article-title":"Case report","volume":"68","author":"Cowen L","year":"2019","unstructured":"Cowen L, Loomis E. Case report. J Fam Pract. 2019;68(9):8-9. https:\/\/cdn.mdedge.com\/files\/s3fs-public\/JFP06811e8.PDF","journal-title":"J Fam Pract"},{"issue":"00078","key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"e00078","DOI":"10.1016\/j.crwh.2018.e00078","article-title":"Ovarian necrosis due to S. pyogenes septic thrombophlebitis: a case report","volume":"20","author":"Gunti\u00f1as A","year":"2018","unstructured":"Gunti\u00f1as A, Kirk JL, Blanco T, P\u00e9rez-Pedregosa J, Rodr\u00edguez MA. Ovarian necrosis due to S. pyogenes septic thrombophlebitis: a case report. Case Rep Womens Health. 2018;20(e00078):e00078.","journal-title":"Case Rep Womens Health"},{"key":"e_1_3_3_25_2","first-page":"1","article-title":"Intrauterine device infection causing concomitant streptococcal toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus bacteraemia","volume":"2016","author":"Wu CMY","year":"2016","unstructured":"Wu CMY, Noska A. Intrauterine device infection causing concomitant streptococcal toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus bacteraemia. BMJ. 2016;2016:1-6.","journal-title":"BMJ"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2010.529962"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2009.05.030"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/13625180903149159"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200208000-00009"},{"issue":"2","key":"e_1_3_3_30_2","first-page":"131","article-title":"Toxic shock syndrome: broadening the differential diagnosis","volume":"14","author":"Herzer CM","year":"2001","unstructured":"Herzer CM. Toxic shock syndrome: broadening the differential diagnosis. J Am Board Fam Pract. 2001;14(2):131-136. https:\/\/www.jabfm.org\/content\/14\/2\/131.long","journal-title":"J Am Board Fam Pract"},{"key":"e_1_3_3_31_2","first-page":"611","article-title":"Toxic shock syndrome associated with a contraceptive diaphragm","volume":"127","author":"DeYoung P","year":"1982","unstructured":"DeYoung P, Martyn J, Wass H, Harth L, Crichton E, Reynolds C. Toxic shock syndrome associated with a contraceptive diaphragm. Can Med Assoc J. 1982;127:611-612.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30636-8"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-382184-3.00013-1"},{"key":"e_1_3_3_34_2","unstructured":"KFF. Intrauterine devices (IUDs): access for women in the US. 2020. Available at: https:\/\/www.kff.org\/womens-health-policy\/fact-sheet\/intrauterine-devices-iuds-access-for-women-in-the-u-s\/#:\u223c:text=Mirena%2C_manufactured_by_Bayer_Healthcare to_treat_heavy_menstrual_bleeding. Accessed 13 December 2023."},{"key":"e_1_3_3_35_2","volume-title":"Lexi-Comp Online","year":"2023","unstructured":"Lexi-Comp Online. Hudson, OH: Lexi-Comp, Inc.; 2023."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6504a1"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002632"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900241313402","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08971900241313402","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900241313402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:33:46Z","timestamp":1777509226000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08971900241313402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/08971900241313402"],"URL":"https:\/\/doi.org\/10.1177\/08971900241313402","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]}}}